kabutan

EIKEN CHEMICAL CO.,LTD.(4549) Summary

4549
TSE Prime
EIKEN CHEMICAL CO.,LTD.
2,904
JPY
-30
(-1.02%)
Mar 13, 3:30 pm JST
18.21
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
25.4
PBR
2.19
Yield
2.00%
Margin Trading Ratio
2.65
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
2,890 JPY 18.14 USD
Previous Close Mar 12
2,934 JPY 18.45 USD
High Mar 13, 10:09 am
2,930 JPY 18.42 USD
Low Mar 13, 9:00 am
2,890 JPY 18.13 USD
Volume
171,900
Trading Value
0.50B JPY 3.13M USD
VWAP
2905.4 JPY 18.23 USD
Minimum Trading Value
290,400 JPY 1,821 USD
Market Cap
0.10T JPY 0.63B USD
Number of Trades
612
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Slightly High
1-Year Average
407
1-Year High Feb 24, 2026
2,050
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 120,900 283,200 2.34
Feb 27, 2026 111,200 222,400 2.00
Feb 20, 2026 123,200 239,400 1.94
Feb 13, 2026 74,600 158,800 2.13
Feb 6, 2026 69,600 160,000 2.30
Company Profile
EIKEN CHEMICAL CO.,LTD. is a leading manufacturer of clinical diagnostic reagents, with a high market share in fecal occult blood test reagents. The company also produces reagents for microbiology, genetic testing, and urinalysis.
Sector
Pharmaceuticals
EIKEN CHEMICAL CO.,LTD. specializes in the manufacture and sale of clinical diagnostic reagents as its core business. The company holds the top domestic market share in fecal occult blood test reagents. It operates both domestically and internationally, with a consolidated subsidiary in China called Eiken China Co., Ltd. This Chinese subsidiary engages in contract manufacturing of the company's diagnostic reagents and the purchase, manufacture, and sale of diagnostic products. The group as a whole focuses on the diagnostic reagent business, maintaining a strong position in the domestic market while expanding overseas. International sales account for approximately one-quarter of the company's total revenue. EIKEN CHEMICAL CO.,LTD. contributes to improving the quality of healthcare by leveraging its technological expertise and product development capabilities in the field of clinical diagnostic reagents.